Acute lymphoblastic leukemia therapeutics may include chemotherapy or targeted drugs that specifically kill cancer cells. Acute lymphoblastic leukemia (ALL) is a type of blood cancer that starts in white blood cells in the bone marrow. It develops from immature lymphocytes, a kind of white blood cell that's key to the immune system. Acute means that the leukemia can progress quickly, and if not treated, would probably be fatal within a few months. Lymphocytic means it develops from early forms of lymphocytes, a type of white blood cell. The survival rate depends on the age of the patient and the type of acute lymphoblastic leukemia therapeutic. However, survival rates continue to improve with newer and improved treatment modalities.
Acute lymphoblastic leukemia (ALL) is a potentially fatal cancer that occurs in bone marrow. Patients with ALL have an inadequate number of immature white blood cells in the bone marrow. This deficiency of immature cells can cause the cells to attack healthy blood cells and produce a dangerous, but treatable cancer known as lymphangiectasia. There are several acute lymphoblastic leukemia therapeutics options available for patients with ALL. With the spinal immobilization, a surgeon will remove the entire median nerve in the spinal cord so that the affected nerve is no longer able to send signals to the body's organs. This method has a very high rate of success.
The second treatment option is chemotherapy. Chemotherapy uses medicines to kill leukemia cells by blocking their ability to divide. It also stops the cancerous cells from multiplying in the blood or on other parts of the body. In order to choose the right treatment for an individual patient, a doctor will evaluate the patient's medical history, the symptoms that he or she is experiencing, and the likelihood of the occurrence of additional health problems in the future. Depending on the type of acute lymphoblastic leukemia cancer and the likelihood of future health problems, the oncology team will assign a specific treatment plan.
Other treatment options include radiation therapy (radiotherapy), bone marrow transplantation, and immunotherapy, which use immune-stimulating drugs to fight off cancer. The best way to learn more about these options is to contact a person who has experienced the same disease, either as a patient or as a survivor. The average five-year survival rate of leukemia is 60-65%. According to the National Cancer Intelligence Network, people with ALL: around 70 out of 100 people (70%) survive their leukaemia for five years or more after they are diagnosed.
Acute lymphoblastic leukemia occurs in both children and adults. It is the most common type of cancer in children, and treatment results in a good chance for a cure. About 90% of those children can be cured with the help of acute lymphoblastic leukemia therapeutics. However, the treatment for acute lymphocytic leukemia can be a long road. Treatment often lasts two to three years. During maintenance phases, children can usually live a relatively normal life and go back to school, whereas adults may be able to continue working. In adults, the main acute lymphoblastic leukemia therapeutics is typically long-term chemotherapy (chemo).